Novel Coronavirus 2019: A Recent Update
DOI:
https://doi.org/10.32734/idjpcr.v3i1.4009Keywords:
Coronavirus, Pneumonia Transmission, Virus, Viral RNA.Abstract
Since last year of December 2019, a virus has been identifying in china’s city of Wuhan, virus name Severe Acute Respiratory Syndrome coronavirus (SARS-CoV-2). 2019 Novel Coronavirus (COVID-19) Disease is a very scary Disease. This disease is a challenge for Human for cure. These virus are effected all over the world’s country like America, Brazil, Turkey, China, Italy, Iran, India, Canada Russia etc., this virus first time reported in relation to the Huainan Seafood Wholesale Market (South China Seafood City Food Market) in Wuhan, China. This market gained media attention after being identified as a point of origin of the 2019–20 coronavirus pandemic. This virus have the common sign & symptoms like pneumonia and show symptoms of fever, headache, joint pain, Common cold, chills, shortness of breath, cough severe pneumonia, dyspnea, renal insufficiency. The detection of 2019- SCoV-like viruses in tiny size, live wild mammals in a market indicates a route of inters species spreading, although the natural loch is not known. This theory assembles a study of the molecular biology fundamental of these infectious agents, with particular prominence on the nature and identify of viral receptors, viral RNA synthesis, and the molecular interactions governing viral assembly.
Downloads
References
JS. Kahn, K. McIntosh, “History and recent advances in coronavirus discovery”, Pediatr. Infect Dis J, vol. 24, no.11, p. 223-227, 2005.
AR. Fehr, S. Perlman, “Coronaviruses: an overview of their replication and pathogenesis”, Methods Mol Biol, 1282, p. 1-23, 2015.
Jasper, FWC., Kin-HK, “Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan”, Emerging Microbes & Infections, vol. 9, p. 221-235, 2020.
WHO. Laboratory testing of human suspected cases of novel coronavirus (nCoV) infection. [Online]. Available from WHO, https://apps.who.int/iris/bitstream/handle/10665/330374/WHO-2019-nCoV-laboratory. [Accessed: May 19, 2020]
WHO. Novel Coronavirus (2019-nCoV) situation report. [Online]. Available from WHO, https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200122-sitrep-2-2019-ncov. [Accessed: May 19, 2020]
Worldometer. Covid-19 corona virus outbreak. [Online]. Available from Worldmeter, https://www.worldometers.info/coronavirus/. [Accessed: May 19, 2020]
VC. Cheng, SK. Lau, PC. Woo, “Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection”, Clin Microbiol Rev, vol. 20, no. 4, p. 660–694, 2007.
Chan JF., SK. Lau, “Middle East respiratory syndrome coronavirus: another zoonotic beta coronavirus causing SARS-like disease”, Clin Microbiol Rev, vol.28, no. 2, p.465–522, 2015.
S. Skariyachan, “Recent aspects on the pathogenesis mechanism animal models and novel therapeutic intervention for MERS-CoV infection’,Front Microbiol, vol. 10, p. 569, 2019.
L. Geng, F. Yaohuao, L. Yanni, “Coronavirus Infections and Immune Responses”, Journal of Medical Virology, vol. 44, p. 2-20, 2020.
KW. Daniel, Pan. ChuYang, “Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia”, American Association for Clinical Chemistry, vol. 2, p.22-26, 2020.
C. Victor, B. Tobias, “Diagnostic detection of Wuhan coronavirus 2019 by real-time. RT-PCR”, Euro serveill, vol. 2, p.1-13, 2020.
L. Michael, M. Vincent, “Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses, including 2019-nCoV”, Nature microbiology, vol. 10, p. 1-26, 2020.
W. Lapps, DA. Brian, “Oligonucleotide Fingerprints of Antigenically Related Bovine Coronavirus and Human Coronavirus 0C43”, Archives of Virology,vol. 86, p. 101—108,1985.
Z. Na, Z. Dingyu, “A Novel Coronavirus from Patients with Pneumonia in China, 2019”, The new England journal of medicine, vol. 328, p. 727-733, 2020.
M. Yue, Z. Yu, “Interaction of cyclophilin a and human coronavirus 229E N protein is essential for virus replication”, Journal Antiviral Res, vol. 10, p. 34-45, 2020.
C. ZhiMin, F. Jun, “Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus” World Journal of Pediatrics, vol. 13, p. 334-337, 2020.
Unicef. Coronavirus disease (COVID-19): What parents should know How to protect yourself and your children. [Online]. Available from Unicef, https://www.unicef.org/bulgaria/en/stories/coronavirus-disease-covid-19-what-parents-should-know . [Accessed: May 20, 2020]
Y. Zhang, “First antiviral drug approved to fight novel coronavirus”, China daily, vol.43, no. 2, p. 1,2020.
WHO. National Health Commission of the People’s Republic of China: Novel Coronavirus (COVID-19). [Online]. Available from WHO, https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd . [Accessed: May 19, 2020]
Published
How to Cite
Issue
Section
Copyright (c) 2020 Indonesian Journal of Pharmaceutical and Clinical Research
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The Authors submitting a manuscript do so on the understanding that if accepted for publication, copyright of the article shall be assigned to Indonesian Journal of Pharmaceutical and Clinical Research (IDJPCR) and Faculty of Pharmacy as well as TALENTA Publisher Universitas Sumatera Utara as publisher of the journal.
Copyright encompasses exclusive rights to reproduce and deliver the article in all form and media. The reproduction of any part of this journal, its storage in databases and its transmission by any form or media, will be allowed only with a written permission from Indonesian Journal of Pharmaceutical and Clinical Research (IDJPCR).
The Copyright Transfer Form can be downloaded here.
The copyright form should be signed originally and sent to the Editorial Office in the form of original mail or scanned document.
